_id
69206f391d3bbaa0018b1a01
Ticker
HSCSW
Name
Heart Test Laboratories Inc. Warrant
Exchange
NASDAQ
Address
550 Reserve Street, Southlake, TX, United States, 76092
Country
USA
Sector
Industry
Currency
USD
Website
https://heartsciences.com
Description
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Last Close
0.0702
Volume
2
Current Price
0.0711
Change
0
Last Updated
2025-12-25T15:22:24.199Z
Image
https://logo.clearbit.com/heartsciences.com
Ipo Date
2022-06-15T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-10-31
Revenue
2419
Cost Of Revenue
33443
Gross Profit
-31024
Operating Expenses
2042379
Operating Income
-2073403
Interest Expense
279534
Pretax Income
-2350769
Net Income
-2350769
Eps
-0.845449516920722
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-2038800
Operating Margin
-85713.22860686235
Total Other Income Expense Net
-277366
Cash
1951103
Short Term Investments
-
Receivables
0
Inventories
657285
Total Current Assets
3793488
Property Plant Equipment
374619
Total Assets
5996117
Payables
317390
Short Term Debt
628977
Long Term Debt
-
Total Liabilities
1813647
Equity
4182470
Depreciation
32435000
Change In Working Capital
-746270
Cash From Operations
-2334266000
Capital Expenditures
13030000
Cash From Investing
-15770000
Cash From Financing
1508908000
Net Change In Cash
-841128000
PE
-
PB
0.0472671090527846
ROE
-56.20528061169596
ROA
-39.204855408925475
FCF
-2347296000
Fcf Percent
-970357.9991732121
Piotroski FScore
0
Health Score
33
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
4
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-10-31
Quarters > 0 > income Statement > revenue
2419
Quarters > 0 > income Statement > cost Of Revenue
33443
Quarters > 0 > income Statement > gross Profit
-31024
Quarters > 0 > income Statement > operating Expenses
2042379
Quarters > 0 > income Statement > operating Income
-2073403
Quarters > 0 > income Statement > interest Expense
279534
Quarters > 0 > income Statement > pretax Income
-2350769
Quarters > 0 > income Statement > net Income
-2350769
Quarters > 0 > income Statement > eps
-0.845449516920722
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2780496
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2038800
Quarters > 0 > income Statement > operating Margin
-85713.22860686235
Quarters > 0 > income Statement > total Other Income Expense Net
-277366
Quarters > 0 > balance Sheet > cash
1951103
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
657285
Quarters > 0 > balance Sheet > total Current Assets
3793488
Quarters > 0 > balance Sheet > property Plant Equipment
374619
Quarters > 0 > balance Sheet > total Assets
5996117
Quarters > 0 > balance Sheet > payables
317390
Quarters > 0 > balance Sheet > short Term Debt
628977
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1813647
Quarters > 0 > balance Sheet > equity
4182470
Quarters > 0 > cash Flow > net Income
-2350769000
Quarters > 0 > cash Flow > depreciation
32435000
Quarters > 0 > cash Flow > change In Working Capital
-746270
Quarters > 0 > cash Flow > cash From Operations
-2334266000
Quarters > 0 > cash Flow > capital Expenditures
13030000
Quarters > 0 > cash Flow > cash From Investing
-15770000
Quarters > 0 > cash Flow > cash From Financing
1508908000
Quarters > 0 > cash Flow > net Change In Cash
-841128000
Quarters > 0 > ratios > PE
-0.845449516920722
Quarters > 0 > ratios > PB
0.0472671090527846
Quarters > 0 > ratios > ROE
-56.20528061169596
Quarters > 0 > ratios > ROA
-39.204855408925475
Quarters > 0 > ratios > FCF
-2347296000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-970357.9991732121
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-07-31
Quarters > 1 > income Statement > revenue
1900
Quarters > 1 > income Statement > cost Of Revenue
760
Quarters > 1 > income Statement > gross Profit
1140
Quarters > 1 > income Statement > operating Expenses
1875259
Quarters > 1 > income Statement > operating Income
-1874119
Quarters > 1 > income Statement > interest Expense
183688
Quarters > 1 > income Statement > pretax Income
-2054994
Quarters > 1 > income Statement > net Income
-2054994
Quarters > 1 > income Statement > eps
-1.5764814365892053
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1303532
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1839631
Quarters > 1 > income Statement > operating Margin
-98637.84210526316
Quarters > 1 > income Statement > total Other Income Expense Net
-180875
Quarters > 1 > balance Sheet > cash
2792231
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
0
Quarters > 1 > balance Sheet > inventories
649507
Quarters > 1 > balance Sheet > total Current Assets
4416595
Quarters > 1 > balance Sheet > property Plant Equipment
403500
Quarters > 1 > balance Sheet > total Assets
6437186
Quarters > 1 > balance Sheet > payables
283225
Quarters > 1 > balance Sheet > short Term Debt
1665293
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3296075
Quarters > 1 > balance Sheet > equity
3141111
Quarters > 1 > cash Flow > net Income
-2054994
Quarters > 1 > cash Flow > depreciation
31675
Quarters > 1 > cash Flow > change In Working Capital
-214556
Quarters > 1 > cash Flow > cash From Operations
-1953367
Quarters > 1 > cash Flow > capital Expenditures
814
Quarters > 1 > cash Flow > cash From Investing
-814
Quarters > 1 > cash Flow > cash From Financing
3648314
Quarters > 1 > cash Flow > net Change In Cash
1694133
Quarters > 1 > ratios > PE
-1.5764814365892053
Quarters > 1 > ratios > PB
0.02950584210491129
Quarters > 1 > ratios > ROE
-65.42252088512632
Quarters > 1 > ratios > ROA
-31.923794030497177
Quarters > 1 > ratios > FCF
-1954181
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1028.5163157894738
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2025-04-30
Quarters > 2 > income Statement > revenue
4350
Quarters > 2 > income Statement > cost Of Revenue
33141
Quarters > 2 > income Statement > gross Profit
-28791
Quarters > 2 > income Statement > operating Expenses
1891608
Quarters > 2 > income Statement > operating Income
-1920399
Quarters > 2 > income Statement > interest Expense
180852
Quarters > 2 > income Statement > pretax Income
-2094330
Quarters > 2 > income Statement > net Income
-2094329
Quarters > 2 > income Statement > eps
-1.8805617812066748
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1113672
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1882217
Quarters > 2 > income Statement > operating Margin
-44147.10344827586
Quarters > 2 > income Statement > total Other Income Expense Net
-173931
Quarters > 2 > balance Sheet > cash
1098098
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4350
Quarters > 2 > balance Sheet > inventories
650267
Quarters > 2 > balance Sheet > total Current Assets
2171457
Quarters > 2 > balance Sheet > property Plant Equipment
435175
Quarters > 2 > balance Sheet > total Assets
4222909
Quarters > 2 > balance Sheet > payables
318661
Quarters > 2 > balance Sheet > short Term Debt
2670688
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
4017738
Quarters > 2 > balance Sheet > equity
205171
Quarters > 2 > cash Flow > net Income
-2094330
Quarters > 2 > cash Flow > depreciation
31261
Quarters > 2 > cash Flow > change In Working Capital
105943
Quarters > 2 > cash Flow > cash From Operations
-1590640
Quarters > 2 > cash Flow > capital Expenditures
7812
Quarters > 2 > cash Flow > cash From Investing
-7812
Quarters > 2 > cash Flow > cash From Financing
100028
Quarters > 2 > cash Flow > net Change In Cash
-1498424
Quarters > 2 > ratios > PE
-1.8805617812066748
Quarters > 2 > ratios > PB
0.385932121011254
Quarters > 2 > ratios > ROE
-1020.7724288520307
Quarters > 2 > ratios > ROA
-49.5944620165862
Quarters > 2 > ratios > FCF
-1598452
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-367.46022988505746
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2025-01-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-67728
Quarters > 3 > income Statement > gross Profit
67728
Quarters > 3 > income Statement > operating Expenses
2371472
Quarters > 3 > income Statement > operating Income
-2371472
Quarters > 3 > income Statement > interest Expense
179477
Quarters > 3 > income Statement > pretax Income
-2536292
Quarters > 3 > income Statement > net Income
-2536292
Quarters > 3 > income Statement > eps
-2.5721555650434
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
986057
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2327848
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-164820
Quarters > 3 > balance Sheet > cash
2596522
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
652147
Quarters > 3 > balance Sheet > total Current Assets
3628954
Quarters > 3 > balance Sheet > property Plant Equipment
466436
Quarters > 3 > balance Sheet > total Assets
5703855
Quarters > 3 > balance Sheet > payables
405076
Quarters > 3 > balance Sheet > short Term Debt
2641235
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3917166
Quarters > 3 > balance Sheet > equity
1786689
Quarters > 3 > cash Flow > net Income
-2536292
Quarters > 3 > cash Flow > depreciation
28967
Quarters > 3 > cash Flow > change In Working Capital
722467
Quarters > 3 > cash Flow > cash From Operations
-1620084
Quarters > 3 > cash Flow > capital Expenditures
15701
Quarters > 3 > cash Flow > cash From Investing
-15701
Quarters > 3 > cash Flow > cash From Financing
180187
Quarters > 3 > cash Flow > net Change In Cash
-1455598
Quarters > 3 > ratios > PE
-2.5721555650434
Quarters > 3 > ratios > PB
0.03923942706313186
Quarters > 3 > ratios > ROE
-141.95486735520285
Quarters > 3 > ratios > ROA
-44.46627763153166
Quarters > 3 > ratios > FCF
-1635785
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
28
Annuals > 0 > quarter
2025-04-30
Annuals > 0 > income Statement > revenue
4350
Annuals > 0 > income Statement > cost Of Revenue
129836
Annuals > 0 > income Statement > gross Profit
-125485
Annuals > 0 > income Statement > operating Expenses
8227085
Annuals > 0 > income Statement > operating Income
-8352571
Annuals > 0 > income Statement > interest Expense
500453
Annuals > 0 > income Statement > pretax Income
-8765229
Annuals > 0 > income Statement > net Income
-8765229
Annuals > 0 > income Statement > eps
-9.342034218769484
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
938257
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-8136820
Annuals > 0 > income Statement > operating Margin
-192013.1264367816
Annuals > 0 > income Statement > total Other Income Expense Net
-412658
Annuals > 0 > balance Sheet > cash
1098098
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4350
Annuals > 0 > balance Sheet > inventories
650267
Annuals > 0 > balance Sheet > total Current Assets
2171457
Annuals > 0 > balance Sheet > property Plant Equipment
435175
Annuals > 0 > balance Sheet > total Assets
4222909
Annuals > 0 > balance Sheet > payables
318661
Annuals > 0 > balance Sheet > short Term Debt
2670688
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4017738
Annuals > 0 > balance Sheet > equity
205171
Annuals > 0 > cash Flow > net Income
-8765229
Annuals > 0 > cash Flow > depreciation
127956
Annuals > 0 > cash Flow > change In Working Capital
517888
Annuals > 0 > cash Flow > cash From Operations
-7412994
Annuals > 0 > cash Flow > capital Expenditures
30188
Annuals > 0 > cash Flow > cash From Investing
-30188
Annuals > 0 > cash Flow > cash From Financing
2733632
Annuals > 0 > cash Flow > net Change In Cash
-4709550
Annuals > 0 > ratios > PE
-9.342034218769484
Annuals > 0 > ratios > PB
0.5757468467765913
Annuals > 0 > ratios > ROE
-4272.157858566757
Annuals > 0 > ratios > ROA
-207.5637670619945
Annuals > 0 > ratios > FCF
-7443182
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1711.0763218390805
Annuals > 0 > health Score
15
Annuals > 1 > quarter
2024-04-30
Annuals > 1 > income Statement > revenue
18600
Annuals > 1 > income Statement > cost Of Revenue
101214
Annuals > 1 > income Statement > gross Profit
-82614
Annuals > 1 > income Statement > operating Expenses
6223156
Annuals > 1 > income Statement > operating Income
-6305770
Annuals > 1 > income Statement > interest Expense
354080
Annuals > 1 > income Statement > pretax Income
-6605208
Annuals > 1 > income Statement > net Income
-6605208
Annuals > 1 > income Statement > eps
-18.73711562464541
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
352520
Annuals > 1 > income Statement > income Tax Expense
-95133
Annuals > 1 > income Statement > EBITDA
-6155995
Annuals > 1 > income Statement > operating Margin
-33901.98924731182
Annuals > 1 > income Statement > total Other Income Expense Net
-299438
Annuals > 1 > balance Sheet > cash
5807648
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
876692
Annuals > 1 > balance Sheet > inventories
629179
Annuals > 1 > balance Sheet > total Current Assets
7353893
Annuals > 1 > balance Sheet > property Plant Equipment
559974
Annuals > 1 > balance Sheet > total Assets
9503113
Annuals > 1 > balance Sheet > payables
448183
Annuals > 1 > balance Sheet > short Term Debt
602293
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2185812
Annuals > 1 > balance Sheet > equity
7317301
Annuals > 1 > cash Flow > net Income
-6605208
Annuals > 1 > cash Flow > depreciation
95133
Annuals > 1 > cash Flow > change In Working Capital
-504363
Annuals > 1 > cash Flow > cash From Operations
-6070185
Annuals > 1 > cash Flow > capital Expenditures
125271
Annuals > 1 > cash Flow > cash From Investing
-125271
Annuals > 1 > cash Flow > cash From Financing
10342637
Annuals > 1 > cash Flow > net Change In Cash
4147181
Annuals > 1 > ratios > PE
-18.73711562464541
Annuals > 1 > ratios > PB
0.006065387770709446
Annuals > 1 > ratios > ROE
-90.26836534399774
Annuals > 1 > ratios > ROA
-69.50572933311432
Annuals > 1 > ratios > FCF
-6195456
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-333.0890322580645
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2023-04-30
Annuals > 2 > income Statement > revenue
5150
Annuals > 2 > income Statement > cost Of Revenue
29711
Annuals > 2 > income Statement > gross Profit
-24561
Annuals > 2 > income Statement > operating Expenses
6088403
Annuals > 2 > income Statement > operating Income
-6112964
Annuals > 2 > income Statement > interest Expense
243174
Annuals > 2 > income Statement > pretax Income
-6354290
Annuals > 2 > income Statement > net Income
-6354290
Annuals > 2 > income Statement > eps
-79.92314948745361
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
79505
Annuals > 2 > income Statement > income Tax Expense
484500000
Annuals > 2 > income Statement > EBITDA
-6084201
Annuals > 2 > income Statement > operating Margin
-118698.33009708738
Annuals > 2 > income Statement > total Other Income Expense Net
-241326
Annuals > 2 > balance Sheet > cash
1660467
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
319381
Annuals > 2 > balance Sheet > inventories
676359
Annuals > 2 > balance Sheet > total Current Assets
2696581
Annuals > 2 > balance Sheet > property Plant Equipment
590652
Annuals > 2 > balance Sheet > total Assets
3287233
Annuals > 2 > balance Sheet > payables
631369
Annuals > 2 > balance Sheet > short Term Debt
529535
Annuals > 2 > balance Sheet > long Term Debt
500000
Annuals > 2 > balance Sheet > total Liabilities
3056676
Annuals > 2 > balance Sheet > equity
230557
Annuals > 2 > cash Flow > net Income
-6354290
Annuals > 2 > cash Flow > depreciation
26915
Annuals > 2 > cash Flow > change In Working Capital
173983
Annuals > 2 > cash Flow > cash From Operations
-5773577
Annuals > 2 > cash Flow > capital Expenditures
18308
Annuals > 2 > cash Flow > cash From Investing
-18308
Annuals > 2 > cash Flow > cash From Financing
6534092
Annuals > 2 > cash Flow > net Change In Cash
742207
Annuals > 2 > ratios > PE
-79.92314948745361
Annuals > 2 > ratios > PB
0.0434152053505207
Annuals > 2 > ratios > ROE
-2756.0603234774917
Annuals > 2 > ratios > ROA
-193.30208719613123
Annuals > 2 > ratios > FCF
-5791885
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1124.63786407767
Annuals > 2 > health Score
15
Annuals > 3 > quarter
2022-04-30
Annuals > 3 > income Statement > revenue
14373
Annuals > 3 > income Statement > cost Of Revenue
34456
Annuals > 3 > income Statement > gross Profit
-20083
Annuals > 3 > income Statement > operating Expenses
4689316
Annuals > 3 > income Statement > operating Income
-4709399
Annuals > 3 > income Statement > interest Expense
371619
Annuals > 3 > income Statement > pretax Income
-4828260
Annuals > 3 > income Statement > net Income
-4828260
Annuals > 3 > income Statement > eps
-145.47771852119678
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
33189
Annuals > 3 > income Statement > income Tax Expense
-250200
Annuals > 3 > income Statement > EBITDA
-4430073
Annuals > 3 > income Statement > operating Margin
-32765.59521324706
Annuals > 3 > income Statement > total Other Income Expense Net
-118861
Annuals > 3 > balance Sheet > cash
918260
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2321
Annuals > 3 > balance Sheet > inventories
674139
Annuals > 3 > balance Sheet > total Current Assets
1930878
Annuals > 3 > balance Sheet > property Plant Equipment
158570
Annuals > 3 > balance Sheet > total Assets
2089447
Annuals > 3 > balance Sheet > payables
694745
Annuals > 3 > balance Sheet > short Term Debt
1720968
Annuals > 3 > balance Sheet > long Term Debt
4441807
Annuals > 3 > balance Sheet > total Liabilities
8145244
Annuals > 3 > balance Sheet > equity
-6055797
Annuals > 3 > cash Flow > net Income
-4828260
Annuals > 3 > cash Flow > depreciation
26566
Annuals > 3 > cash Flow > change In Working Capital
1124745
Annuals > 3 > cash Flow > cash From Operations
-3644144
Annuals > 3 > cash Flow > capital Expenditures
1932
Annuals > 3 > cash Flow > cash From Investing
-1932
Annuals > 3 > cash Flow > cash From Financing
3840855
Annuals > 3 > cash Flow > net Change In Cash
194779
Annuals > 3 > ratios > PE
-145.47771852119678
Annuals > 3 > ratios > PB
-0.0006899992024171221
Annuals > 3 > ratios > ROE
79.7295550032473
Annuals > 3 > ratios > ROA
-231.07836666830983
Annuals > 3 > ratios > FCF
-3646076
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-253.6753635288388
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.845449516920722
Valuation > metrics > PB
0.0472671090527846
Valuation > final Score
70
Valuation > verdict
95.3% Undervalued
Profitability > metrics > ROE
-56.20528061169596
Profitability > metrics > ROA
-61.968536607997706
Profitability > metrics > Net Margin
-971.7937164117404
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.433630605838177
Risk > metrics > Interest Coverage
-7.41735531277054
Risk > final Score
30
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.008474513587224
Liquidity > metrics > Quick Ratio
3.3139395181784654
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-11
Prev Risks > 1
-36
Prev Risks > 2
-35
Prev Liquidities > 0
100
Prev Liquidities > 1
35
Prev Liquidities > 2
79
Updated At
2026-01-20T23:12:01.980Z
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATrading Recap: Is PPTA benefiting from innovation trends - Weekly Market Outlook & AI Powered Buy/Sell Recommendations baoquankhu1.vn
Read more →Will Sensient Technologies Corporation stock remain on Wall Street radar - 2025 Volume Leaders & Momentum Based Trading Ideas bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-10-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Heart Test Laboratories Inc. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-10-31)
(Last Updated 2025-10-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-10-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-10-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.